JP2004537554A5 - - Google Patents

Download PDF

Info

Publication number
JP2004537554A5
JP2004537554A5 JP2003513970A JP2003513970A JP2004537554A5 JP 2004537554 A5 JP2004537554 A5 JP 2004537554A5 JP 2003513970 A JP2003513970 A JP 2003513970A JP 2003513970 A JP2003513970 A JP 2003513970A JP 2004537554 A5 JP2004537554 A5 JP 2004537554A5
Authority
JP
Japan
Prior art keywords
compound
optionally substituted
phenyl
pharmaceutical composition
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2003513970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004537554A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/022897 external-priority patent/WO2003008411A1/en
Publication of JP2004537554A publication Critical patent/JP2004537554A/ja
Publication of JP2004537554A5 publication Critical patent/JP2004537554A5/ja
Ceased legal-status Critical Current

Links

JP2003513970A 2001-07-19 2002-07-18 置換されたピペラジン化合物および脂肪酸酸化インヒビターとしてのその使用 Ceased JP2004537554A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30662101P 2001-07-19 2001-07-19
PCT/US2002/022897 WO2003008411A1 (en) 2001-07-19 2002-07-18 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

Publications (2)

Publication Number Publication Date
JP2004537554A JP2004537554A (ja) 2004-12-16
JP2004537554A5 true JP2004537554A5 (https=) 2006-01-05

Family

ID=23186103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003513970A Ceased JP2004537554A (ja) 2001-07-19 2002-07-18 置換されたピペラジン化合物および脂肪酸酸化インヒビターとしてのその使用

Country Status (21)

Country Link
US (1) US6930111B2 (https=)
EP (1) EP1406898B1 (https=)
JP (1) JP2004537554A (https=)
KR (1) KR100919141B1 (https=)
CN (1) CN1533388A (https=)
AT (1) ATE292633T1 (https=)
AU (1) AU2008202958A1 (https=)
CA (1) CA2454059A1 (https=)
DE (1) DE60203623T2 (https=)
DK (1) DK1406898T3 (https=)
ES (1) ES2236557T3 (https=)
HU (1) HUP0402088A3 (https=)
IL (1) IL159897A0 (https=)
MX (1) MXPA04000565A (https=)
NO (1) NO327635B1 (https=)
NZ (1) NZ530705A (https=)
PL (1) PL368529A1 (https=)
PT (1) PT1406898E (https=)
RU (1) RU2300533C2 (https=)
WO (1) WO2003008411A1 (https=)
ZA (1) ZA200400404B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001909B2 (en) * 2001-07-19 2006-02-21 Cv Therapeutics, Inc. Substituted heterocyclic compounds
US8822473B2 (en) 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
MXPA04011530A (es) 2002-05-21 2005-08-15 Cv Therapeutics Inc Administracion de un inhibidor de acido graso parcial tal como ranolazina para el tratamiento de diabetes.
AU2003264018A1 (en) 2002-08-09 2004-02-25 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
MXPA05001592A (es) * 2002-08-09 2005-05-05 Astrazeneca Ab Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico.
IL166510A0 (en) 2002-08-09 2006-01-15 Nps Pharma Inc 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
EP1806346B1 (en) * 2002-12-05 2009-07-22 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
AU2003300827B2 (en) * 2002-12-05 2009-08-13 Gilead Palo Alto, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
NZ541069A (en) 2003-01-03 2008-09-26 Cv Therapeutics Inc Piperazine derivatives as fatty acid oxidation inhibitors
NZ541306A (en) * 2003-01-17 2008-07-31 Cv Therapeutics Inc Substituted piperazine and piperidine derivatives useful in the treatment of cardiovascular diseases
NZ544449A (en) * 2003-06-23 2008-10-31 Cv Therapeutics Inc Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
EP1723129A1 (en) * 2003-12-18 2006-11-22 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
US7959659B2 (en) * 2004-01-02 2011-06-14 Advanced Cardiovascular Systems, Inc. High-density lipoprotein coated medical devices
WO2006029179A2 (en) * 2004-09-08 2006-03-16 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
WO2008023248A2 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
US8088920B2 (en) * 2008-03-31 2012-01-03 Hoffmann-La Roche Inc. 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
HRP20170357T1 (hr) 2008-10-10 2017-05-05 Vm Discovery, Inc. Sastavi i postupci za liječenje poremećaja zbog konzumacije alkohola, bolova i ostalih bolesti
JP2012526848A (ja) * 2009-05-14 2012-11-01 ギリアード サイエンシーズ, インコーポレイテッド Cns障害の治療のためのラノラジン
JPWO2011115150A1 (ja) * 2010-03-18 2013-07-04 興和株式会社 ベンゾチアジン化合物の製造方法
CN111285819A (zh) * 2018-12-07 2020-06-16 江苏恩华药业股份有限公司 一种苯并噁唑类化合物及其应用
WO2023023995A1 (zh) * 2021-08-25 2023-03-02 苏州大学 一种防治心肌缺血后心功能衰竭的药物及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133989A (en) 1964-12-08 1968-11-20 Chugai Pharmaceutical Co Ltd Theophylline derivatives, their salts and process for preparing the same
DE2834114A1 (de) * 1978-08-01 1980-02-14 Schering Ag Polyalkoxyphenylpyrrolidone iii, verfahren zu ihrer herstellung und ihre verwendung
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
JPS6137765A (ja) * 1984-07-19 1986-02-22 サンド・アクチエンゲゼルシヤフト 3‐アミノプロポキシアリール誘導体
US4723014A (en) * 1986-11-19 1988-02-02 Warner-Lambert Company Process for the preparation of 2-substituted-1,4-dihydropyridines
DE3723648A1 (de) * 1987-07-17 1989-01-26 Sandoz Ag Indol-derivate, ihre herstellung und sie enthaltende arzneimittel
JPH0699399B2 (ja) * 1988-10-06 1994-12-07 三井東圧化学株式会社 新規複素環化合物およびそれを有効成分として含有する製癌剤効果増強剤
JPH02268162A (ja) * 1989-04-10 1990-11-01 Fujisawa Pharmaceut Co Ltd ジフェニルピリジン誘導体
MX9308025A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.
EP0938480A1 (en) * 1996-11-14 1999-09-01 American Home Products Corporation Substituted tetrahydro-1,3,5-triazin-2 1h]-thiones as anti-atherosclerotic agents
HK1044777B (en) * 1999-09-13 2006-04-13 Wyeth Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
AU2001238590A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted piperazine compounds
US6451798B2 (en) 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
IL151178A0 (en) 2000-02-22 2003-04-10 Cv Therapeutics Inc Substituted piperazine compounds
US6552023B2 (en) 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
AU2001239827A1 (en) * 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
US6573264B1 (en) 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives

Similar Documents

Publication Publication Date Title
JP2004537554A5 (https=)
RU2004104951A (ru) Замещенные пиперазиновые соединения и их применение в качестве ингибиторов окисления жирных кислот
JP2015533157A5 (https=)
JP2013519680A5 (https=)
EP2712616B1 (en) Intermediates for the preparation of 1-(acetyl)-piperidine and 1-(acetyl)-piperazine derivatives as fungicides for use in plant protection
RU2379299C2 (ru) Производные 5-(бенз-(z)-илиден)тиазолидин-4-она и их применение в качестве иммуносупрессорных агентов
JP2009525984A5 (https=)
JP2004534035A5 (https=)
JP2006506340A5 (https=)
JP2009519965A5 (https=)
JP2005526815A5 (https=)
RU2004127928A (ru) Производные морфолинилмочевины для использования в лечении воспалительных заболеваний
RU2383524C2 (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2018535999A5 (https=)
JP2006503081A5 (https=)
JP2010513319A5 (https=)
JP2014510132A5 (https=)
JP2010513397A5 (https=)
JP2006513258A5 (https=)
JP2004517080A5 (https=)
JP2009544742A5 (https=)
JP2006517572A5 (https=)
JP2006502134A5 (https=)
JP2007510713A5 (https=)
RU2006119623A (ru) Аллостерические модуляторы метаботропных глутаматных рецепторов